Submit RFI/RFP
Request Consultation
FeaturedProlonged-release opioids
The indication for post-operative pain management has been removed The indication for the management of post-operative pain has been removed from the licenses of all prolonged release opioids,…
Newsroom
News
155 articles
Featured
FeaturedThe EU has introduced a new clinical trial map
A new clinical trial map is now available on the Clinical Trials Information System (CTIS) public website. The map is intended to offer patients and healthcare professionals with…
FeaturedFirst Treatment Approval for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease
Adults with cerebrotendinous xanthomatosis (CTX) can now be treated with Ctexli (chenodiol), which is approved by the US Food and Drug Administration. Also, it’s The first FDA-approved medication…
FeaturedThe first rapid-acting insulin biosimilar product approved by the FDA for the treatment of diabetes
For the purpose of improving glycemic control in adults and pediatric patients with diabetes mellitus, the U.S. Food and Drug Administration authorized Merilog (insulin-aspart-szjj) as a biosimilar to…
FeaturedThe FDA warns patients that while using smartphone-compatible diabetes devices, they may miss critical safety alerts due to phone settings
In order to provide vital safety alerts, the U.S. Food and Drug Administration is warning patients about a safety issue with diabetic devices that rely on smartphones, including…
FeaturedNemolizumab is approved for treating patients with prurigo nodularis and atopic dermatitis (eczema)
Nemolizumab, also known as Nemluvio, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat moderate to severe prurigo nodularis in adults aged 18…
FeaturedThe medical imaging agent gozetotide has been approved for the diagnosis of prostate cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of gozetotide (marketed under the name Illuccix) in a positioning emission tomography (PET) scan, a form…
FeaturedChikungunya vaccine authorization for Adults
The MHRA has authorized the chikungunya vaccine (live) (brand name IXCHIQ) to prevent adults from chikungunya disease, which is caused by the chikungunya virus (CHIKV). CHIKV is spread…
FeaturedMHRA seeks feedback on proposed recommendations to facilitate the safe regulation of emerging personalized cancer medicines
The Medicines and Healthcare Products Regulatory Agency (MHRA) has opened a consultation on regulatory guidance for personalized mRNA cancer immunotherapies (also known as cancer vaccines). This is a…
FeaturedNew combination of drugs to treat parasitic worm infections
The EMA’s human medicines committee (CHMP) has issued a good scientific opinion on Ivermectin/Albendazole for the treatment of illnesses caused by a variety of worm parasites, including lymphatic…
FeaturedOne Health: EU agencies collaborate to address azole fungicide resistance in Aspergillus fungus due to the extensive use of azoles
The widespread use of azole fungicides (azoles), notably in some agricultural and horticultural operations, raises the possibility of Aspergillus fungus acquiring resistance to critical antifungal treatments. This noteworthy…
FeaturedThe FDA has approved the first drug in a new class of non-opioid pain medicines
The FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx alleviates pain by inhibiting…
FeaturedNew approval for treatment and prevention of angioedema attacks
The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved garadacimab (brand name Andembry) for the prevention of angioedema attacks in individuals aged 12 and up with hereditary…
FeaturedThe FDA is suggesting a substantial step toward reducing nicotine levels in cigarettes and other combusted tobacco products to a minimal or nonaddictive level
If approved, the United States would be the world’s first government to adopt such a bold, life-saving step to prevent and decrease smoking-related disease and death. The FDA…
FeaturedHighlighted safety warnings about possible side effects of Montelukast
Extra safety information is being added to all montelukast products, Montelukast is a prescription medicine used to prevent and treat chronic asthma in adults and children aged 2…
Ready to simplify your journey?
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP